Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
01/2003
01/29/2003EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
01/29/2003EP1278827A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
01/29/2003EP1278826A1 Novel proteins
01/29/2003EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents
01/29/2003EP1278776A2 Isolated human transporter proteins, nucleic acids and uses thereof
01/29/2003EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
01/29/2003EP1278774A2 Human g-protein coupled receptors
01/29/2003EP1278772A2 Glucagon antagonists
01/29/2003EP1278770A1 Human wingless-like gene
01/29/2003EP1278767A1 Albumin fusion proteins
01/29/2003EP1278766A2 Polynucleotides for diagnosing mammary gland cancer
01/29/2003EP1278764A2 Compounds and methods for the treatment and prevention of bacterial infection
01/29/2003EP1278546A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
01/29/2003EP1278545A1 Combination therapy of respiratory diseases using antibodies
01/29/2003EP1278544A2 Albumin fusion proteins
01/29/2003EP1278543A2 Antibody binding alpha4beta7 integrin and its use to treat inflammatory bowel disease
01/29/2003EP1278540A2 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
01/29/2003EP1278538A1 Cd18-binding antibodies inhibit stenosis-related disorders
01/29/2003EP1278534A1 Methods and compositions for impairing multiplication of hiv-1
01/29/2003EP0858465B1 Anti-tumoral protein
01/29/2003EP0846266B1 Differential assay for ulcerative colitis, primary sclerosing cholangitis and type 1 autoimmune hepatitis
01/29/2003EP0754192B1 Circularly permuted ligands and circularly permuted chimeric molecules
01/29/2003EP0703980B1 Intracellular binding proteins and use thereof
01/29/2003CN1394138A Hair growth stimulant
01/29/2003CN1393557A Polypeptide-human protein-14.08 containing peptidyl-prolyl cis-trans isomerase characteristic sequence fragment and polynucleotide for coding it
01/29/2003CN1393555A Polypeptide-proteasome-61.82 and polynucleotide for coding it
01/29/2003CN1393554A Polypeptide-human protein-9.57 containing glycosylhydrolase family 17 characteristic sequence fragment and polynucleotide for coding it
01/29/2003CN1393553A Polypeptide-human phosphatidase-30.47 and polynucleotide for coding it
01/29/2003CN1393552A Polypeptide-human myotonic dystrophy protein kinase -61.27 and polynucleotide for coding it
01/29/2003CN1393551A Plypeptide-human hepatouracil dinucleotide glycosyltransferase -29.7 and polynucleotide for coding it
01/29/2003CN1393550A Polypeptide-human respiratory chain CoQ oxide-reductase-11.22 and polynucleotide for coding it
01/29/2003CN1393549A Polypeptide-trypsinogen-26.51 and polynucleotide for coding it
01/29/2003CN1393548A Polypeptide-human protein-13.2 containing site specific recombinase characteristic sequence fragrant and polynucleotide for coding it
01/29/2003CN1393547A Polypeptide-human protein-9.35 containing cytosine specific DNA methylase characteristic sequence fragment and polynucleotide for coding it
01/29/2003CN1393475A Micromolecular lung cancer antibody targeted immunotoxin and its equipment, preparing process and usage
01/29/2003CN1393473A Polypeptide-phorbolester/diglyceride protein-9.57 and polynucleotide for coding it
01/29/2003CN1393472A Polypeptide-Sec24 protein-31.35 and polynucleotide for coding it
01/29/2003CN1393471A Polypeptide-zinc finger protein-78.54 and polynucleotide for coding it
01/29/2003CN1393470A Polypeptide-beta transducin-45.65 and polynucleotide for coding it
01/29/2003CN1393469A Polypeptide-prop-cell junction associated protein-24.86 and polynucleotide for coding it
01/29/2003CN1393468A Polypeptide-fibrinogen-42.68 and polynucleotide for coding it
01/29/2003CN1393467A Polypeptide-human thymocyte signal transducer-14.52 and polynucleotide for coding it
01/29/2003CN1393466A Polypeptide-ribonucleic acid bindin-31.13 and polynucleotide for coding it
01/29/2003CN1393465A Polypeptide-human protein-12.43 containing ribosomal protein S24e characteristic sequence fragment and polynucleotide for coding it
01/29/2003CN1393464A Polypeptide-growth factor receptor-15.95 and polynucleotide for coding it
01/29/2003CN1393463A Polypeptide-accessory factor-15.84 and polynucleotide for coding it
01/29/2003CN1393462A Polypeptide-membrane transporter-14.85 and polynucleotide for coding it
01/29/2003CN1393461A Polypeptide-iodothyrine transporter-22.88 and polynucleotide for coding it
01/29/2003CN1393460A Polypeptide-reticulocyte finger protein-31.57 and polynucleotide for coding it
01/29/2003CN1393459A Polypeptide-bone development associated protein-43.23 and polynucleotide for coding it
01/29/2003CN1393458A Polypeptide-C2 function region contained protein-56.65 and polynucleotide for coding it
01/29/2003CN1393457A Polypeptide-Na/glucose cotransporter family-72.05 and polynucleotide for coding it
01/29/2003CN1393456A Polypeptide-zinc finger protein-61.05 and polynucleotide for coding it
01/29/2003CN1393455A Polypeptide-zinc finger protein-57.86 and polynucleotide for coding it
01/29/2003CN1393454A Polypeptide-human macroprotein-31.68 and polynucleotide for coding it
01/29/2003CN1393453A Activator protein for fibrin dissolving system
01/29/2003CN1393452A Memory clearing protein and its application
01/29/2003CN1099894C Vaccine composition for eliciting immune response against N-glycolylated gangliosides and its use
01/28/2003US6512104 Interleukin-1β converting enzyme like cysteine protease
01/28/2003US6512103 Mammalian chemokine reagents
01/28/2003US6512097 Chimeric molecules that specifically bind a tumor cell bearing a c-erbB-2; immunotherapy
01/28/2003US6512096 Prostate cell surface antigen-specific antibodies
01/28/2003US6511825 Cell signaling polypeptides and nucleic acids
01/28/2003US6511801 HIV-1 group O strain gp160 env precursor protein comprising the amino acid sequence of SEQ ID NO:100
01/28/2003US6511666 Purified antigenic complex comproised of multimeric protein complexes of arginine- and lysine-specific thiol endopepti-dases containing adhesion domains; raising antibody response against porphyromonas gingivalis
01/28/2003US6511664 Antiinflammatory
01/28/2003US6511663 Tri- and tetra-valent monospecific antigen-binding proteins
01/28/2003US6511662 Treatment of cytomegalovirus using aminopeptidase N
01/28/2003CA2072008C Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains
01/24/2003WO2002008456A2 Method for identifying metastatic tumor cells
01/24/2003CA2416697A1 Method for identifying metastasizing tumor cells
01/23/2003WO2003006996A2 Natural ligand of gpcr chemr23 and uses thereof
01/23/2003WO2003006893A2 Methods of inhibiting amyloid toxicity
01/23/2003WO2003006672A2 Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
01/23/2003WO2003006665A1 Lawsonia intracellularis
01/23/2003WO2003006619A2 Calcineurin modulators
01/23/2003WO2003006609A2 Human cytokine receptor
01/23/2003WO2003006607A2 Inhibition of apoptosis process and improvement of cell performance
01/23/2003WO2003006509A2 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
01/23/2003WO2003006508A1 A monoclonal antibody, methods of producing it and the use thereof
01/23/2003WO2003006507A1 Method of preparing antinarcotic shellfish toxin antibody, novel antibody, elisa kit with the use of the antibody and labelled toxin sample prepared by the method
01/23/2003WO2003006506A2 Protease inhibitor conjugates and antibodies useful in immunoassay
01/23/2003WO2003006499A2 Survivin interacting protein tpr1
01/23/2003WO2003006493A2 Histidine phosphatase interacting protein with 180kd
01/23/2003WO2003006059A1 Vegfr-1 antibodies to treat breast cancer
01/23/2003WO2003006058A1 Cd25+ differential markers and uses thereof
01/23/2003WO2003006057A1 Composition and method for the treatment of disease
01/23/2003WO2003006055A2 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
01/23/2003WO2003006045A2 Cxcl10 treatment of secondary tissue degeneration
01/23/2003WO2003005888A2 Lipophilin complexes for use in cancer diagnosis and therapy
01/23/2003WO2002098908A9 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
01/23/2003WO2002086058A3 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
01/23/2003WO2002066509A3 Treatment involving dkk-1 or antagonists thereof
01/23/2003WO2002048388A9 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
01/23/2003WO2002047466A3 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
01/23/2003WO2002046364A9 Genes associated with mechanical stress, expression products therefrom, and uses thereof
01/23/2003WO2002036741A3 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
01/23/2003WO2002029059A3 Nogo receptor homologs
01/23/2003WO2002028903A3 Heavy chain libraries
01/23/2003WO2002022659A3 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II